Comprehensive sequencing of the LRRK2 gene in patients with familial Parkinson's disease from North Africa

Movement Disorders

Volumn 25, Issue 13, 2010, Pages 2052-2058

  Jasinska Myga, Barbara ^a,b   Kachergus, Jennifer ^a   Vilariño Güell, Carles ^a   Wider, Christian ^a   Soto Ortolaza, Alexandra I ^a   Kefi, Mounir ^c   Middleton, Lefkos T ^d   Ishihara Paul, Lianna ^e   Gibson, Rachel A ^e   Amouri, Rim ^c   Yahmed, Samia Ben ^c   Sassi, Samia Ben ^c   Zouari, Mourad ^c   El Euch, Ghada ^c   Ross, Owen A ^a   Hentati, Faycal ^c   Farrer, Matthew J ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c Institut National de Neurologie Tunisia   (Tunisia)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Arab Berbers; Familial Parkinson's disease; Genetics; LRRK2; Parkinson's disease; Sequencing

Indexed keywords

LEUCINE RICH REPEAT KINASE 2;

AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ASSESSMENT; CONTROLLED STUDY; DNA SEQUENCE; ETHNICITY; FAMILIAL PARKINSON DISEASE; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NORTH AFRICA; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ADULT; AFRICA, NORTHERN; AGED; AGED, 80 AND OVER; EXONS; FAMILY HEALTH; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; PARKINSONIAN DISORDERS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; SEQUENCE ANALYSIS, DNA;

EID: 78649372272     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23283     Document Type: Article

References (26)

1. Farrer MJ. Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet 2006;7:306-318.
2. Paisan-Ruiz C, Jain S, Evans EW, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004;44:595-600.
3. Zimprich A, Muller-Myhsok B, Farrer M, et al. The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval. Am J Hum Genet 2004;74:11-19.
4. Hulihan MM, Ishihara-Paul L, Kachergus J, et al. LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study. Lancet Neurol 2008;7:591-594.
5. Lesage S, Durr A, Tazir M, et al. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N Engl J Med 2006;354:422-423.
6. Ishihara L, Gibson RA, Warren L, et al. Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families. Mov Disord 2007;22:55-61.
7. Orr-Urtreger A, Shifrin C, Rozovski U, et al. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect? Neurology 2007;69:1595-1602.
8. Ozelius LJ, Senthil G, Saunders-Pullman R, et al. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med 2006;354:424-425.
9. Tan EK, Shen H, Tan LC, et al. The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients. Neurosci Lett 2005;384:327-329.
10. Di Fonzo A, Wu-Chou YH, Lu CS, et al. A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan. Neurogenetics 2006;7:133-138.
11. Farrer MJ, Stone JT, Lin CH, et al. Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia. Parkinsonism Relat Disord 2007;13:89-92.
12. Ross OA, Wu YR, Lee MC, et al. Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease. Ann Neurol 2008;64:88-92.
13. Lesage S, Condroyer C, Lannuzel A, et al. Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson's disease. J Med Genet 2009;46:458-464.
14. Di Fonzo A, Tassorelli C, De Mari M, et al. Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease. Eur J Hum Genet 2006;14:322-331.
15. Paisan-Ruiz C, Lang AE, Kawarai T, et al. LRRK2 gene in Parkinson disease: mutation analysis and case control association study. Neurology 2005;65:696-700.
16. Paisan-Ruiz C, Nath P, Washecka N, Gibbs JR, Singleton AB. Comprehensive analysis of LRRK2 in publicly available Parkinson's disease cases and neurologically normal controls. Hum Mutat 2008;29:485-490.
17. Johnson J, Paisan-Ruiz C, Lopez G, et al. Comprehensive screening of a North American Parkinson's disease cohort for LRRK2 mutation. Neurodegener Dis 2007;4:386-391.
18. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
19. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
20. Mata IF, Kachergus JM, Taylor JP, et al. Lrrk2 pathogenic substitutions in Parkinson's disease. Neurogenetics 2005;6: 171-177.
21. Lesage S, Ibanez P, Lohmann E, et al. G2019S LRRK2 mutation in French and North African families with Parkinson's disease. Ann Neurol 2005;58:784-787.
22. Gandhi PN, Chen SG, Wilson-Delfosse AL. Leucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson's disease. J Neurosci Res 2009;87:1283-1295.
23. Nuytemans K, Rademakers R, Theuns J, et al. Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson's disease patients. Eur J Hum Genet 2008;16:471-479.
24. Camargos ST, Dornas LO, Momeni P, et al. Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations. Mov Disord 2009;24:662-666.
25. Paisan-Ruiz C. LRRK2 gene variation and its contribution to Parkinson disease. Hum Mutat 2009;30:1153-1160.
26. Taylor JP, Hulihan MM, Kachergus JM, et al. Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's disease. Neurogenetics 2007;8:95-102.